Medical Debt Protection Act; created, prohibited practices, penalties.
HB1725 establishes the Medical Debt Protection Act in Virginia and adds a new chapter to Title 59.1 of the Code of Virginia. The act defines key terms such as medical debt, medical creditor, medical debt collector, medical debt buyer, large health care facility, financial assistance policy, emergency services, and urgent services. It then sets new rules governing billing and collection of medical debt, including limits on interest and late fees, restrictions on when collection actions may begin, notice requirements before extraordinary collection actions, and conditions that must be met before medical debt may be sold to a debt buyer.
The bill prohibits a range of aggressive collection practices for medical debt, such as arrest, body attachment, foreclosure on real property, liens on personal property, and wage garnishment for patients eligible for financial assistance. It also requires large health care facilities and medical debt collectors to provide advance notice before taking extraordinary collection actions and to include information about financial assistance when applicable. If a patient overpays, the bill requires a refund of excess amounts within 60 days after the overpayment is determined. Violations of the new chapter are treated as prohibited practices under the Virginia Consumer Protection Act, making the act enforceable through existing consumer protection remedies.
The bill amends Virginia’s Consumer Protection Act, specifically 59.1-200, to add violations of the new Medical Debt Protection Act as prohibited practices. It creates a new statutory chapter in Title 59.1, effective July 1, 2026, that directly regulates hospitals, large outpatient practices, medical debt buyers, and medical debt collectors. The act changes how medical debt may be billed, sold, and collected in Virginia, and it limits the use of certain legal remedies and collection tactics while tying compliance to consumer-protection enforcement and penalties.
The bill appears to have had mixed but ultimately sufficient support, with several close votes in committee and on the floor indicating substantial debate. It passed the House and Senate with notable margins but also drew significant opposition, and later votes on the Governor’s recommendations and on passage in enrolled form were rejected. Overall, the sentiment suggests broad interest in medical debt relief and consumer protection, paired with persistent concern about the scope and operational impact of the restrictions on health care providers and debt collectors.
The main points of contention appear to center on how far the state should go in restricting medical debt collection and whether the bill places too many burdens on hospitals, large medical practices, and debt buyers. Opponents likely objected to limits on interest, late fees, debt sales, and extraordinary collection actions, as well as the requirement that sellers remain liable for buyers’ conduct. Supporters likely emphasized protecting patients from harsh collection tactics and ensuring access to financial assistance and clearer billing practices. The close votes suggest disagreement over balancing consumer protection against provider revenue recovery and collection flexibility.